Alamar Biosciences announces death of board member Ian Ratcliffe; board size reduced to five

Alamar Biosciences, Inc.

Independent director Ian Ratcliffe, who served since February 2024, passed away on July 5, 2026.
Board decreased authorized directors from six to five following Mr. Ratcliffe's passing.
Nicholas Naclerio, Ph.D., appointed to the Audit Committee of the Board.

item 8.01

Alamar Biosciences, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-26-304736

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.